Acutaas Chemicals Ltd (ACUTAAS) is currently trading at 4,010.00 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Acutaas Chemicals manufactures advanced pharmaceutical intermediates and specialty chemicals, serving global pharmaceutical, battery-materials and emerging semiconductor applications. The company is transitioning from a predominantly pharma-focused platform into a broader specialty chemicals business through new facilities, higher-value products, international manufacturing and targeted capacity expansion. H1 FY27 revenue grew 49.3% to ₹7,666 million, while EBITDA nearly doubled to ₹2,890 million and the margin expanded to 37.7%. The improvement was driven primarily by advanced intermediates, which represented 91% of revenue, stronger gross margins and operating leverage, despite a contraction in specialty chemicals revenue. The company inaugurated its South Korea facility ahead of schedule, creating a new manufacturing base for high-purity chemicals used in photoresists, semiconductor packaging and etching applications. This is strategically important because it gives Acutaas Chemicals exposure to semiconductor materials while diversifying its geographic and end-market footprint. Management raised FY27 revenue growth guidance from 25% to approximately 30% and increased EBITDA margin guidance to 38–40%. The upgrade reflects stronger revenue visibility and a robust order pipeline, although the presentation does not quantify backlog, customer concentration, utilization or the precise contribution expected from newer facilities.

Over the past 52 weeks, Acutaas Chemicals Ltd has traded between a low of ₹1,571.20 and a high of ₹4,031.85. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Acutaas Chemicals Ltd has a market capitalization of approximately 32,597.40. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Acutaas Chemicals Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 74.32 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 32,597.40 Cr, Acutaas Chemicals Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Acutaas Chemicals Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Acutaas Chemicals Ltd is 74.32. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

Acutaas Chemicals reported revenue from operations of ₹329.67 crore in the quarter ended June 2026, up 59.08% year-on-year.

The company has scheduled a board meeting on July 24, 2026 to consider financial results, and it will hold an earnings call the same day at 4:00 PM IST for Q1 FY27.

Acutaas Chemicals is scheduled to hold a board meeting on July 24, 2026 to consider the audited financial results.

The material cites a board meeting on July 24, 2026 to consider results, while other sections reference an indicative July-August 2026 window and a July 29, 2026 tracker date.